Cushman & Wakefield
CWK
11.42
-0.52
-4.36%
Cushman & Wakefield
US · CWK
#2556 by market cap
Listed 2018
11.42
-0.52
-4.36%
Live - 5344 symbols - heartbeat 55s ago
· 2026-10-07 19:54
After-hours
11.42
0.00%
- Market cap
- 2.68B
- P/E (TTM)i
- 38.07
- P/Bi
- 1.33
- EPSi
- 0.38
- Div yieldi
- 0.00%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on CWK?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Cushman & Wakefield: Seattle, D.C. Metro and Chicago Recorded the Strongest Growth in Sales Activity Among Leading Metros CWKDow Jones · 2026/9/1
-
Cushman & Wakefield: U.S. Life Sciences Market Is Moving Through Necessary Period of Adjustment as It Absorbs the Significant Amount of Space Delivered in Recent Years CWKDow Jones · 2026/9/1
-
Rating change
Morgan Stanley Maintains Cushman & Wakefield(CWK.US) With Buy Rating, Raises Target Price to $19Market Newswire · 2026/1/17
-
Rating change
Barclays Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Raises Target Price to $19Market Newswire · 2026/1/13
-
Rating change
Barclays Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Maintains Target Price $15Market Newswire · 2026/8/6
-
J.P. Morgan Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Raises Target Price to $19Market Newswire · 2026/9/2
-
Cushman & Wakefield: Transaction Activity Remained Concentrated in the Largest Markets, Top Five U.S. Metros Acctg for 81% of Total R&D Deal Volume in 1H CWKDow Jones · 2026/9/1
-
Rating change
Goldman Sachs Maintains Cushman & Wakefield(CWK.US) With Buy Rating, Raises Target Price to $19Market Newswire · 2026/8/19
-
Rating change
Barclays Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Raises Target Price to $16Market Newswire · 2026/8/17
-
Rating change
Goldman Sachs Maintains Cushman & Wakefield(CWK.US) With Buy Rating, Raises Target Price to $19.5Market Newswire · 2026/2/27
-
Rating change
UBS Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Cuts Target Price to $15Market Newswire · 2026/8/10
-
Cushman & Wakefield: Overall U.S. Life Sciences Vacancy Rate Increased From 23.4% at Yr-end 2025 to 24.3% in 2Q CWKDow Jones · 2026/9/1
-
Rating change
William Blair Maintains Cushman & Wakefield(CWK.US) With Buy RatingMarket Newswire · 2026/8/6
-
Rating change
Wolfe Research Upgrades Cushman & Wakefield(CWK.US) to Buy Rating, Announces Target Price $19Market Newswire · 2026/2/9
-
Rating change
Goldman Sachs Maintains Cushman & Wakefield(CWK.US) With Buy Rating, Cuts Target Price to $17Market Newswire · 2026/5/22
-
Rating change
Barclays Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Maintains Target Price $19Market Newswire · 2026/2/24
-
Rating change
Morgan Stanley Maintains Cushman & Wakefield(CWK.US) With Buy Rating, Maintains Target Price $19Market Newswire · 2026/8/6
-
Rating change
Goldman Sachs Maintains Cushman & Wakefield(CWK.US) With Buy Rating, Maintains Target Price $17Market Newswire · 2026/6/6
-
Rating change
J.P. Morgan Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Cuts Target Price to $18Market Newswire · 2026/6/3
-
Rating change
Barclays Maintains Cushman & Wakefield(CWK.US) With Hold Rating, Cuts Target Price to $15Market Newswire · 2026/3/13
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.